Marcus

US · MCS #3399 by market cap

27.07 -0.09 -0.33%

Live - 5344 symbols - heartbeat 91s ago · 2026-10-09 19:30

✦ Quant Financial Health how this is computed

Fair

Altman Z-Score is 1.98, in the 1.8-3.0 "grey zone".
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +3.11% YoY

Margins

Gross margin: 38.68%
Operating margin: 2.86%
Net margin: 1.67%

Key ratios & quality

Enterprise value: 989.23M
Altman Z-Score: 1.98

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	707.12M	820.86M	237.69M	458.24M	677.39M	729.58M	735.56M	758.46M
Gross profit	307.62M	329.48M	51.14M	183.74M	257.39M	286.54M	287.36M	293.39M
Selling & admin expenses	107.16M	124.20M	88.99M	105.01M	124.67M	127.56M	139.43M	143.90M
Research & development	--	--	--	--	--	--	--	--
Operating profit	83.19M	70.07M	-153.75M	-35.69M	9.83M	35.03M	23.38M	21.68M
Pretax profit	66.59M	54.44M	-195.80M	-58.99M	-1.97M	21.65M	-10.21M	8.71M
Tax	13.13M	12.32M	-70.94M	-15.70M	7.14M	6.86M	-2.42M	-3.98M
Net profit	53.47M	42.12M	-124.87M	-43.29M	-9.10M	14.79M	-7.79M	12.69M
Basic EPS	2	1	-4	-1	0	0	0	0
Diluted EPS	1.86	1.35	-4.13	-1.42	-0.39	0.46	-0.25	0.41

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Revenue	148.77M	206.04M	210.15M	193.50M	154.40M	231.74M
Gross profit	47.25M	81.42M	89.85M	74.87M	50.73M	95.52M
Selling & admin expenses	36.18M	35.97M	36.39M	35.36M	37.23M	36.82M
Research & development	--	--	--	--	--	--
Operating profit	-21.78M	13.19M	22.66M	7.61M	-19.18M	27.18M
Pretax profit	-24.17M	10.07M	24.19M	-1.38M	-22.99M	23.99M
Tax	-7.36M	2.75M	7.96M	-7.33M	-7.64M	8.15M
Net profit	-16.82M	7.32M	16.23M	5.96M	-15.35M	15.84M
Basic EPS	-1	0	1	0	-1	1
Diluted EPS	-0.54	0.23	0.52	0.19	-0.51	0.51

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	68.95M	79.26M	67.82M	99.95M	63.90M	109.99M	100.86M	73.68M
Cash & ST investments	22.42M	26.69M	8.16M	22.28M	25.64M	60.95M	48.98M	23.45M
Inventory	4.14M	5.67M	3.43M	4.91M	5.66M	5.91M	6.97M	7.03M
Total assets	989.33M	1.36B	1.25B	1.19B	1.06B	1.07B	1.04B	1.01B
Total current liabilities	149.26M	174.99M	217.39M	213.17M	156.40M	164.42M	176.68M	163.44M
Short-term debt	15.87M	25.82M	120.14M	77.67M	27.47M	28.17M	28.49M	19.05M
Long-term debt	228.86M	206.43M	193.04M	204.18M	170.01M	159.55M	149.01M	159.01M
Total liabilities	499,212,000.00	737,728,000.00	755,455,000.00	734,747,000.00	607,677,000.00	593,931,000.00	579,662,000.00	557,154,000.00
Total equity	490.12M	621.46M	498.72M	453.61M	456.92M	471.17M	464.87M	457.38M
Retained earnings	439.18M	461.88M	331.90M	289.31M	274.25M	281.60M	265.03M	268.56M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Total current assets	59.77M	61.01M	50.72M	73.68M	50.43M	71.72M
Cash & ST investments	11.87M	14.90M	7.39M	23.45M	11.23M	26.35M
Inventory	--	--	--	7.03M	--	--
Total assets	1.02B	1.02B	1.00B	1.01B	992.06M	999.55M
Total current liabilities	142.81M	156.53M	144.21M	163.44M	145.20M	164.75M
Short-term debt	28.35M	28.62M	19.03M	19.05M	18.94M	18.97M
Long-term debt	189.06M	170.12M	161.95M	159.01M	174.06M	149.12M
Total liabilities	576,166,000.00	567,889,000.00	549,956,000.00	557,154,000.00	550,891,000.00	542,665,000.00
Total equity	441.79M	448.42M	454.34M	457.38M	441.17M	456.88M
Retained earnings	246.03M	251.20M	265.01M	268.56M	250.80M	264.23M

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	137.39M	141.48M	-68.55M	46.25M	93.21M	102.63M	103.94M	84.20M
Depreciation & amortization	61.68M	72.28M	75.05M	72.13M	67.07M	67.30M	67.96M	70.19M
Free cash flow	78.73M	77.39M	-89.92M	29.17M	56.37M	63.86M	24.73M	989.00K
Dividends paid	-16.41M	-19.31M	-5.15M	0	-3.08M	-7.45M	-8.78M	-9.16M
Stock buybacks / issuance	-2.52M	-702.00K	-534.00K	-417.00K	-1.47M	-503.00K	-9.99M	-18.55M
Ending cash balance	21.93M	25.62M	14.09M	24.05M	24.51M	59.84M	44.58M	26.58M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Operating cash flow	-35.33M	31.64M	39.09M	48.80M	-15.22M	53.96M
Depreciation & amortization	17.84M	17.60M	16.84M	17.92M	17.84M	17.35M
Free cash flow	-58.33M	14.73M	18.20M	26.40M	-21.87M	43.96M
Dividends paid	-2.18M	-2.15M	-2.43M	-2.40M	-2.41M	-2.41M
Stock buybacks / issuance	-7.63M	16.00K	-9.11M	-1.83M	-2.31M	-386.00K
Ending cash balance	15.72M	16.70M	10.48M	26.58M	14.35M	30.99M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	11.42	7.56	-22.29	-9.09	-2.63	3.19	-1.66	2.75
ROA %	5.32	3.58	-9.55	-3.54	-1.06	1.39	-0.74	1.23
ROIC %	8.30	5.49	-10.56	-2.91	0.01	2.74	0.07	2.70
5-year avg ROE %	--	--	4.46	0.63	-3.01	-4.65	-6.50	-1.49
EBIT margin %	11.27	8.07	-75.53	-8.79	1.97	4.71	0.10	2.66
FCF / sales %	11.13	9.43	--	6.37	8.32	8.75	3.36	0.13
Current ratio	0.46	0.45	0.31	0.47	0.41	0.67	0.57	0.45
Quick ratio	0.36	0.35	0.22	0.37	0.30	0.49	0.40	0.26
Debt / assets	26.98	35.70	44.93	43.35	38.30	35.59	33.76	33.07
LT debt / equity	51.24	73.92	88.89	96.43	83.38	74.47	69.73	69.18
Interest coverage	6.09	5.62	-11.03	-2.15	0.87	2.70	0.07	1.76
Revenue CAGR (3Y) %	10.88	12.64	-28.62	-13.46	-6.20	45.33	17.09	3.84
Net income CAGR (3Y) %	24.96	3.50	--	--	--	--	--	--
FCF CAGR (3Y) %	110.29	--	--	-28.18	-10.03	--	-5.35	-74.01

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
ROE %	-2.83	3.30	1.68	2.75	3.21	5.01
ROA %	-1.25	1.43	0.75	1.23	1.41	2.25
ROIC %	-0.39	2.94	2.05	2.70	2.58	4.17
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	-0.52	2.72	2.16	2.66	2.77	4.41
FCF / sales %	--	--	0.23	0.13	4.90	8.44
Current ratio	0.42	0.39	0.35	0.45	0.35	0.44
Quick ratio	0.21	0.24	0.20	0.26	0.19	0.28
Debt / assets	38.16	35.92	34.11	33.07	35.27	32.01
LT debt / equity	81.51	75.03	71.21	69.18	75.02	65.88
Interest coverage	-0.35	1.81	1.43	1.76	1.88	3.16
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Lead segment, long tail

Theatres is the largest reported line at 65.04% of revenue, across 2 reported segments.
Hotels/Resorts follows at 34.96%, so the top line still matters most but isn’t the whole story.

Revenue breakdown most recent period

Business

Theatres65.04%

Hotels/Resorts34.96%

Quote time 2026-10-09 19:30:06 · For reference only, not investment advice and not tailored to your situation.